Uncontrolled Hypertension: Clinical Trials

3 trials for Uncontrolled Hypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Uncontrolled Hypertension: new trials by email Literature Review of Uncontrolled Hypertension trials Research Report on Uncontrolled Hypertension

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension
Baxdrostat, Placebo - Uncontrolled Hypertension
Phase 2CompletedAstraZeneca482024-06-102025-12-17
A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease
CIN-107, Placebo - Uncontrolled Hypertension, Chronic Kidney Diseases
Phase 2CompletedAstraZeneca1952022-04-292025-05-20
A Study of CIN-107 in Patients With Uncontrolled Hypertension
CIN-107, Placebo - Uncontrolled Hypertension
Phase 2CompletedCinCor Pharma, Inc.2492021-12-072023-08-01

Narrower conditions

Renal Insufficiency, Chronic (1)

Broader conditions

Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Sponsors

AstraZeneca (2)  ·  CinCor Pharma, Inc. (1)

Countries

United States (3)

Results publications

PMID 37490693, PMID 40913594